Back to search
Neonatal Abstinence Syndrome
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Neonatal Abstinence Syndrome trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Neonatal Abstinence Syndrome trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Infants with neonatal abstinence syndrome (NAS) experience prolonged hospital stays and poor neurodevelopmental outcomes, in-part because of the lack of accurat…
Neonatal Abstinence Syndrome (NAS), is a common and costly problem in Alberta that affects approximately 250 babies per year exposed to drugs during pregnancy.…
The purpose of this study is to address the gap in maternal OUD treatment and infant neonatal opioid withdrawal syndrome care. The research team will develop a…
This study examines the effects of 6 different music therapy interventions on outcomes for neonates diagnosed with Neonatal Abstinence Syndrome.
The primary objective of this study is to evaluate the impact of treating opioid use disorder (OUD) in pregnant women with extended-release buprenorphine (BUP-X…
The objective of this study is to determine if tAN therapy can reduce the median number of days of oral morphine administered to an infant after start of treatm…